ACTAVIS

Nature of Business: Manufacturer (Factory)

Company Overview:

Actavis Indonesia is a prominent pharmaceutical manufacturing company operating as a subsidiary of the global Teva Pharmaceutical Industries. The company specializes in the development, production, and distribution of high-quality generic pharmaceutical products. Its facility in Indonesia functions as a fully integrated manufacturing plant, adhering to international Good Manufacturing Practice (GMP) standards. Actavis Indonesia focuses on providing affordable healthcare solutions across various therapeutic categories, serving both the domestic market and contributing to the global supply chain of the Teva group.

Actavis Indonesia, which is now part of the Teva Pharmaceutical Industries group, specializes in a wide range of generic pharmaceutical products. Their portfolio in Indonesia primarily includes the following categories:

Anti-Infectives

Amoxicillin

Ciprofloxacin

Cefixime

Azithromycin

Cardiovascular Agents

Amlodipine

Atorvastatin

Bisoprolol

Lisinopril

Central Nervous System Drugs

Diazepam

Amitriptyline

Fluoxetine

Risperidone

Gastrointestinal Medications

Omeprazole

Lansoprazole

Domperidone

Metabolic and Endocrine Products

Metformin

Glibenclamide

Pain Management and Anti-Inflammatory Drugs

Ibuprofen

Meloxicam

Diclofenac

Respiratory Medications

Salbutamol

Ambroxol

Note: Product availability may vary based on local regulatory approvals and current market distribution strategies under the Teva/Actavis brand.